Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study

• V Blaha,
• R Margoczy,
• I Petrov,
• A Postadzhiyan,
• K Raslova,
• H Rosolova,
• I Bridges,
• NN Dhalwani,
• M Zachlederova,
• KK Ray

Affiliations

V Blaha

University Hospital Hradec Kralove and Charles University, Hradec Kralove, Czech Republic

R Margoczy

Middle Slovak Institute of Cardiovascular Diseases, Banska Bystrica, Slovakia

I Petrov

University Hospital Acibadem City Clinic and Sofia University St Kliment Ohridski, Sofia, Bulgaria

A Postadzhiyan

Medical University of Sofia, Sofia, Bulgaria

K Raslova

Slovak Medical University, National Reference Centre for Familial Hyperlipoproteinemias, Bratislava, Slovakia

H Rosolova

Charles University of Pilsen, Center of Preventive Cardiology, Pilsen, Czech Republic

I Bridges

Amgen UK, Uxbridge, UK

NN Dhalwani

Amgen UK, Uxbridge, UK

M Zachlederova

Amgen, Prague, Czechia

KK Ray

Imperial College London, London, UK